Blog
Q&A with Suzanne Zwicker, clinical pharmacist
In this Q&A, Suzanne Zwicker, Clinical Pharmacist on the National Pharmacy Team for Innomar in Dartmouth, Nova Scotia, responds to...
Regional Therapy for Colorectal Cancer Liver Metastases
July 2022 Patients who have colorectal cancer that has spread to the liver (liver metastases) and cannot be removed by...
Minimal Residual Disease (MRD) and CRC
June 2022 Minimal residual disease (MRD) is a term that refers to cancer cells that remain after treatment has ended,...
HER2 Therapies for Patients with mCRC
HER2 (human epidermal growth factor receptor 2) is a protein receptor found in all human cells and is responsible for controlling cell growth and repair. When the HER2 gene acquires mutations which cause it to be amplified or overexpressed in the cell, it promotes the growth and metastasis of different cancers, including colorectal cancer.
Overall survival associated with Pembrolizumab (Keytruda) vs. Chemotherapy in MSI-H/dMMR mCRC
May 2022 The KEYNOTE-177 trial is a landmark study in colorectal cancer treatment that evaluated the efficacy and safety of...
